These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19200778)

  • 1. No apparent difference in the prevalence of parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan.
    Kato YH; Yamate M; Tsujikawa M; Nishigaki H; Tanaka Y; Yunoki M; Kuratsune H; Watanabe Y; Ikuta K
    J Clin Virol; 2009 Mar; 44(3):246-7. PubMed ID: 19200778
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
    Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
    J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.
    Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN
    Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parvovirus B19 infection and its clinical picture].
    Dudina KR; Znoĭko OO; Iushchuk ND
    Ter Arkh; 2007; 79(11):75-8. PubMed ID: 18219981
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient.
    Brodin-Sartorius A; Mekki Y; Pastural M; Billaud G; Daoud S; Chauvet C; Touraine JL; Lina B; Morelon E; Thaunat O
    Transpl Infect Dis; 2011 Feb; 13(1):97-8. PubMed ID: 20636481
    [No Abstract]   [Full Text] [Related]  

  • 6. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
    Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
    Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome.
    Attard L; Bonvicini F; Gelsomino F; Manfredi R; Cascavilla A; Viale P; Varani S; Gallinella G
    J Clin Virol; 2015 Jan; 62():54-7. PubMed ID: 25542471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
    Seishima M; Mizutani Y; Shibuya Y; Arakawa C
    Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningoencephalitis associated with human parvovirus B19.
    Coskun O; Erdem H; Gul HC; Besirbellioglu BA; Sener K; Eyigun CP
    Clin Microbiol Infect; 2008 Dec; 14(12):1188-90. PubMed ID: 19076847
    [No Abstract]   [Full Text] [Related]  

  • 10. Human parvovirus B19-associated myocarditis.
    Bock CT; Klingel K; Kandolf R
    N Engl J Med; 2010 Apr; 362(13):1248-9. PubMed ID: 20357294
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute parvovirus B19 infection mimicking chronic fatigue syndrome.
    Matano S; Kinoshita H; Tanigawa K; Terahata S; Sugimoto T
    Intern Med; 2003 Sep; 42(9):903-5. PubMed ID: 14518687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.
    Bonvicini F; Marinacci G; Pajno MC; Gallinella G; Musiani M; Zerbini M
    Clin Infect Dis; 2008 Aug; 47(3):385-7. PubMed ID: 18558883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study on the seroprevalence of parvovirus B19 in Amsterdam.
    van Rijckevorsel GG; Sonder GJ; Schim van der Loeff MF; van den Hoek JA
    J Med Virol; 2009 Jul; 81(7):1305-9. PubMed ID: 19475607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
    J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological mechanisms of parvovirus B19 infection.
    Noutsias M; Pankuweit S; Maisch B
    J Clin Microbiol; 2009 Jul; 47(7):2358-9; author reply 2359. PubMed ID: 19574588
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulminant myocarditis associated with parvovirus B19 infection in a child.
    Dina J; Vabret A; Rambaud C; Checoury A; Gouarin S; Petitjean J; Freymuth F
    J Clin Virol; 2008 May; 42(1):70-1. PubMed ID: 18313977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection].
    Frotscher B; Salignac S; Morlon L; Bonmati C; Jeulin H; Venard V; Lecompte T
    Ann Biol Clin (Paris); 2009; 67(3):343-8. PubMed ID: 19411238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia.
    Ooi SL; Hooi PS; Chua BH; Lam SK; Chua KB
    Med J Malaysia; 2002 Mar; 57(1):97-103. PubMed ID: 14569725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic manifestations associated with parvovirus B19 infection.
    Douvoyiannis M; Litman N; Goldman DL
    Clin Infect Dis; 2009 Jun; 48(12):1713-23. PubMed ID: 19441978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients.
    Frémont M; Metzger K; Rady H; Hulstaert J; De Meirleir K
    In Vivo; 2009; 23(2):209-13. PubMed ID: 19414405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.